{"id": "article-25022_0", "title": "Mesenteric Venous Thrombosis -- Continuing Education Activity", "content": "Mesenteric venous thrombosis, characterized by acute, subacute, or chronic thrombosis in the superior or inferior mesenteric vein and branches, poses a significant risk of life-threatening intestinal infarction, accounting for 5% to 15% of mesenteric ischemic events.\u00a0Patients with mesenteric venous thrombosis present with a range of signs and symptoms, from mild abdominal pain to hemodynamic instability secondary to septic shock. Mesenteric venous thrombosis may occur due to a primary coagulopathy or an underlying infectious, traumatic, or inflammatory condition. The acuity and extent of the thrombus will dictate the course of the disease and the recommended intervention. However, delays in diagnosis and treatment cause significant increases in morbidity and mortality.", "contents": "Mesenteric Venous Thrombosis -- Continuing Education Activity. Mesenteric venous thrombosis, characterized by acute, subacute, or chronic thrombosis in the superior or inferior mesenteric vein and branches, poses a significant risk of life-threatening intestinal infarction, accounting for 5% to 15% of mesenteric ischemic events.\u00a0Patients with mesenteric venous thrombosis present with a range of signs and symptoms, from mild abdominal pain to hemodynamic instability secondary to septic shock. Mesenteric venous thrombosis may occur due to a primary coagulopathy or an underlying infectious, traumatic, or inflammatory condition. The acuity and extent of the thrombus will dictate the course of the disease and the recommended intervention. However, delays in diagnosis and treatment cause significant increases in morbidity and mortality."}
{"id": "article-25022_1", "title": "Mesenteric Venous Thrombosis -- Continuing Education Activity", "content": "This activity for healthcare professionals reviews the epidemiology, etiology, pathophysiology, clinical manifestations, evaluation, management, and complications of acute, subacute, and chronic mesenteric venous thrombosis. The activity also highlights the critical role of the interprofessional team in improving outcomes for patients with mesenteric venous thrombosis.", "contents": "Mesenteric Venous Thrombosis -- Continuing Education Activity. This activity for healthcare professionals reviews the epidemiology, etiology, pathophysiology, clinical manifestations, evaluation, management, and complications of acute, subacute, and chronic mesenteric venous thrombosis. The activity also highlights the critical role of the interprofessional team in improving outcomes for patients with mesenteric venous thrombosis."}
{"id": "article-25022_2", "title": "Mesenteric Venous Thrombosis -- Continuing Education Activity", "content": "Objectives: Identify\u00a0patients at risk for or who may have a mesenteric venous thrombosis based on their clinical history and presentation. Select the most appropriate diagnostic imaging modality for a patient with a suspected mesenteric venous thrombosis. Create a tailored treatment plan for a patient with a mesenteric venous thrombosis. Develop and implement effective interprofessional team strategies to improve outcomes for patients with mesenteric venous thrombosis. Access free multiple choice questions on this topic.", "contents": "Mesenteric Venous Thrombosis -- Continuing Education Activity. Objectives: Identify\u00a0patients at risk for or who may have a mesenteric venous thrombosis based on their clinical history and presentation. Select the most appropriate diagnostic imaging modality for a patient with a suspected mesenteric venous thrombosis. Create a tailored treatment plan for a patient with a mesenteric venous thrombosis. Develop and implement effective interprofessional team strategies to improve outcomes for patients with mesenteric venous thrombosis. Access free multiple choice questions on this topic."}
{"id": "article-25022_3", "title": "Mesenteric Venous Thrombosis -- Introduction", "content": "Mesenteric venous thrombosis is a\u00a0clot within the superior or inferior mesenteric vein or its branches. Thrombosis may be secondary to an inherited or acquired thrombophilia or as a consequence of or in conjunction with a proinflammatory state.\u00a0Factors contributing to mesenteric venous thrombus formation include injury, stasis, malignancy, infection, trauma, and systemic inflammation. While\u00a0greater than 25%\u00a0of cases of mesenteric venous thrombosis may initially appear idiopathic, with\u00a0thorough evaluation, many are shown to have an identifiable etiology.\u00a0The thrombosis can originate in the vena rectae or a major vein and may involve the portal vein. The superior mesenteric vein is involved in more than 90% of cases of mesenteric vein thrombosis, whereas the inferior mesenteric vein is only implicated in up to 11% of cases.", "contents": "Mesenteric Venous Thrombosis -- Introduction. Mesenteric venous thrombosis is a\u00a0clot within the superior or inferior mesenteric vein or its branches. Thrombosis may be secondary to an inherited or acquired thrombophilia or as a consequence of or in conjunction with a proinflammatory state.\u00a0Factors contributing to mesenteric venous thrombus formation include injury, stasis, malignancy, infection, trauma, and systemic inflammation. While\u00a0greater than 25%\u00a0of cases of mesenteric venous thrombosis may initially appear idiopathic, with\u00a0thorough evaluation, many are shown to have an identifiable etiology.\u00a0The thrombosis can originate in the vena rectae or a major vein and may involve the portal vein. The superior mesenteric vein is involved in more than 90% of cases of mesenteric vein thrombosis, whereas the inferior mesenteric vein is only implicated in up to 11% of cases."}
{"id": "article-25022_4", "title": "Mesenteric Venous Thrombosis -- Introduction", "content": "Mesenteric venous thrombosis may be an acute, subacute, or chronic process. Venous thrombi account for 5% to 15% of cases of acute mesenteric ischemia and are responsible for 1 in\u00a05000 to 15,000 inpatient admissions and 1 in 1000 emergency department visits. Chronic mesenteric venous thrombosis accounts for 20% to 40% of all cases and is often an incidental finding. Although mesenteric venous thrombosis\u00a0is a relatively rare condition, mortality remains high due to nonspecific symptoms\u00a0and delayed diagnosis. [1] [2]", "contents": "Mesenteric Venous Thrombosis -- Introduction. Mesenteric venous thrombosis may be an acute, subacute, or chronic process. Venous thrombi account for 5% to 15% of cases of acute mesenteric ischemia and are responsible for 1 in\u00a05000 to 15,000 inpatient admissions and 1 in 1000 emergency department visits. Chronic mesenteric venous thrombosis accounts for 20% to 40% of all cases and is often an incidental finding. Although mesenteric venous thrombosis\u00a0is a relatively rare condition, mortality remains high due to nonspecific symptoms\u00a0and delayed diagnosis. [1] [2]"}
{"id": "article-25022_5", "title": "Mesenteric Venous Thrombosis -- Introduction", "content": "The location, acuity, and extent of the thrombus affect the prognosis. Patients with chronic thrombosis may have complications stemming from venous hypertension, including malnutrition and esophageal or gastric varices.\u00a0Chronic thrombi\u00a0promote the formation of\u00a0collaterals that protect the bowel from ischemic changes, but when a thrombus arises acutely, mesenteric ischemia may develop quickly; acute ischemia disrupts the intestinal mucosal barrier, promoting bacterial translocation and resulting in sepsis, multisystem organ failure, and death.", "contents": "Mesenteric Venous Thrombosis -- Introduction. The location, acuity, and extent of the thrombus affect the prognosis. Patients with chronic thrombosis may have complications stemming from venous hypertension, including malnutrition and esophageal or gastric varices.\u00a0Chronic thrombi\u00a0promote the formation of\u00a0collaterals that protect the bowel from ischemic changes, but when a thrombus arises acutely, mesenteric ischemia may develop quickly; acute ischemia disrupts the intestinal mucosal barrier, promoting bacterial translocation and resulting in sepsis, multisystem organ failure, and death."}
{"id": "article-25022_6", "title": "Mesenteric Venous Thrombosis -- Introduction", "content": "Treatment of mesenteric venous thrombosis ranges from temporary anticoagulation with management of the underlying proinflammatory disorder to prolonged intensive care unit admission\u00a0and urgent surgical intervention. The goal of treatment is to protect tissue, prevent the extension of the thrombosis, and minimize the chances of recurrence. Anticoagulation is often a mainstay of therapy. Anticoagulation is recommended even for those patients with varices, but patients with symptomatic varices may require decompression of their venous hypertension before they are anticoagulated.", "contents": "Mesenteric Venous Thrombosis -- Introduction. Treatment of mesenteric venous thrombosis ranges from temporary anticoagulation with management of the underlying proinflammatory disorder to prolonged intensive care unit admission\u00a0and urgent surgical intervention. The goal of treatment is to protect tissue, prevent the extension of the thrombosis, and minimize the chances of recurrence. Anticoagulation is often a mainstay of therapy. Anticoagulation is recommended even for those patients with varices, but patients with symptomatic varices may require decompression of their venous hypertension before they are anticoagulated."}
{"id": "article-25022_7", "title": "Mesenteric Venous Thrombosis -- Etiology", "content": "Hypercoagulable states are\u00a0present\u00a0in 60% to 75% of patients with\u00a0mesenteric\u00a0venous thrombosis. Often, an inherited or acquired thrombophilia coexists with trauma, infection, inflammation, or surgery to give rise to a thrombotic process. Thrombosis may also arise from stasis, such as heart failure or cirrhosis. Hypercoagulable conditions include malignancies, heparin-induced thrombocytopenia, essential thrombocythemia, polycythemia vera, antiphospholipid antibodies, oral contraceptive use, and pregnancy.\u00a0Heritable hypercoagulable\u00a0conditions include sickle cell disease, Factor V Leiden, excess prothrombotic factors, and deficiencies in antithrombin III or proteins C or S. [3] [4] [5]", "contents": "Mesenteric Venous Thrombosis -- Etiology. Hypercoagulable states are\u00a0present\u00a0in 60% to 75% of patients with\u00a0mesenteric\u00a0venous thrombosis. Often, an inherited or acquired thrombophilia coexists with trauma, infection, inflammation, or surgery to give rise to a thrombotic process. Thrombosis may also arise from stasis, such as heart failure or cirrhosis. Hypercoagulable conditions include malignancies, heparin-induced thrombocytopenia, essential thrombocythemia, polycythemia vera, antiphospholipid antibodies, oral contraceptive use, and pregnancy.\u00a0Heritable hypercoagulable\u00a0conditions include sickle cell disease, Factor V Leiden, excess prothrombotic factors, and deficiencies in antithrombin III or proteins C or S. [3] [4] [5]"}
{"id": "article-25022_8", "title": "Mesenteric Venous Thrombosis -- Etiology", "content": "Patients with a thrombus in a major mesenteric vein often have concurrent\u00a0portal vein thrombosis; such persons are more likely to have an underlying localized condition such as inflammatory bowel disease, pancreatitis, diverticulitis, myeloproliferative neoplasms, and malignancies. Portal vein involvement is also higher in persons with cirrhosis and has been reported in 15% of people awaiting liver transplantation. Patients with smaller vessel thrombosis in the vena rectae are more likely to have systemic thrombophilia. [6]", "contents": "Mesenteric Venous Thrombosis -- Etiology. Patients with a thrombus in a major mesenteric vein often have concurrent\u00a0portal vein thrombosis; such persons are more likely to have an underlying localized condition such as inflammatory bowel disease, pancreatitis, diverticulitis, myeloproliferative neoplasms, and malignancies. Portal vein involvement is also higher in persons with cirrhosis and has been reported in 15% of people awaiting liver transplantation. Patients with smaller vessel thrombosis in the vena rectae are more likely to have systemic thrombophilia. [6]"}
{"id": "article-25022_9", "title": "Mesenteric Venous Thrombosis -- Etiology", "content": "While up to 25% of cases of mesenteric vein thrombosis may initially be construed as idiopathic, thorough evaluation often reveals the causative etiology. For example, the gain-of-function JAK2V617F mutation results in a blood cell line proliferation; an assay for this mutation helps diagnose those with subclinical myeloproliferative disorders and\u00a0can distinguish an inherited prothrombotic state from a reactive condition. The mutation is detected in most cases of polycythemia vera and 50% of cases of essential thrombocythemia and myelofibrosis. In addition, the JAK2V617F mutation is reported in up to 46% of cases without overt myeloproliferative neoplasms. [6] [7] [8]", "contents": "Mesenteric Venous Thrombosis -- Etiology. While up to 25% of cases of mesenteric vein thrombosis may initially be construed as idiopathic, thorough evaluation often reveals the causative etiology. For example, the gain-of-function JAK2V617F mutation results in a blood cell line proliferation; an assay for this mutation helps diagnose those with subclinical myeloproliferative disorders and\u00a0can distinguish an inherited prothrombotic state from a reactive condition. The mutation is detected in most cases of polycythemia vera and 50% of cases of essential thrombocythemia and myelofibrosis. In addition, the JAK2V617F mutation is reported in up to 46% of cases without overt myeloproliferative neoplasms. [6] [7] [8]"}
{"id": "article-25022_10", "title": "Mesenteric Venous Thrombosis -- Epidemiology", "content": "Acute\u00a0mesenteric\u00a0venous thrombosis\u00a0causes 5% to 15% of all cases of mesenteric ischemia and accounts for 1 in 5,000 to 15,000 inpatient admissions and 1 in 1000 emergency department visits. The incidence of mesenteric venous thrombosis is estimated to be 2.7 per 100,000 persons. Computed tomography (CT) has increased the number of cases diagnosed during evaluation for other reasons, and this imaging modality identifies approximately 90% of\u00a0mesenteric\u00a0venous thromboses.\u00a0Although mortality remains between 19% and 23%,\u00a0there has been a trend toward earlier diagnosis and improved outcomes. Mesenteric\u00a0venous thrombosis\u00a0is slightly more common in men and most frequently presents in persons between the ages of 40 and 60. [9] [3]", "contents": "Mesenteric Venous Thrombosis -- Epidemiology. Acute\u00a0mesenteric\u00a0venous thrombosis\u00a0causes 5% to 15% of all cases of mesenteric ischemia and accounts for 1 in 5,000 to 15,000 inpatient admissions and 1 in 1000 emergency department visits. The incidence of mesenteric venous thrombosis is estimated to be 2.7 per 100,000 persons. Computed tomography (CT) has increased the number of cases diagnosed during evaluation for other reasons, and this imaging modality identifies approximately 90% of\u00a0mesenteric\u00a0venous thromboses.\u00a0Although mortality remains between 19% and 23%,\u00a0there has been a trend toward earlier diagnosis and improved outcomes. Mesenteric\u00a0venous thrombosis\u00a0is slightly more common in men and most frequently presents in persons between the ages of 40 and 60. [9] [3]"}
{"id": "article-25022_11", "title": "Mesenteric Venous Thrombosis -- Pathophysiology", "content": "The superior mesenteric vein returns\u00a0blood from the bowel from the second portion of the duodenum to the proximal two-thirds of the transverse colon, joining the splenic vein posterior to the neck of the pancreas, forming the portal vein. The left gastric vein drains the lower part of the esophagus and a portion of the lesser curvature of the stomach and enters the portal system at the formation of the portal vein.\u00a0The inferior mesenteric vein drains the left colon and enters the splenic vein.", "contents": "Mesenteric Venous Thrombosis -- Pathophysiology. The superior mesenteric vein returns\u00a0blood from the bowel from the second portion of the duodenum to the proximal two-thirds of the transverse colon, joining the splenic vein posterior to the neck of the pancreas, forming the portal vein. The left gastric vein drains the lower part of the esophagus and a portion of the lesser curvature of the stomach and enters the portal system at the formation of the portal vein.\u00a0The inferior mesenteric vein drains the left colon and enters the splenic vein."}
{"id": "article-25022_12", "title": "Mesenteric Venous Thrombosis -- Pathophysiology", "content": "The pathophysiology of mesenteric venous thrombosis depends on the acuity, location, and causative etiology of the thrombus.\u00a0Systemic\u00a0thrombophilia\u00a0causes thrombi within the vena rec. In contrast, local factors, such as intraabdominal malignancy, pancreatitis, and diverticulitis, produce thrombi in the superior mesenteric vein, often with extension into the portal vein.", "contents": "Mesenteric Venous Thrombosis -- Pathophysiology. The pathophysiology of mesenteric venous thrombosis depends on the acuity, location, and causative etiology of the thrombus.\u00a0Systemic\u00a0thrombophilia\u00a0causes thrombi within the vena rec. In contrast, local factors, such as intraabdominal malignancy, pancreatitis, and diverticulitis, produce thrombi in the superior mesenteric vein, often with extension into the portal vein."}
{"id": "article-25022_13", "title": "Mesenteric Venous Thrombosis -- Pathophysiology", "content": "Thrombi within the\u00a0small, more distal venous branches pose\u00a0a risk for bowel infarction. Blood return from the bowel is impeded, resulting in venous engorgement and subsequent ischemia. Arterial spasms can also contribute to irreversible ischemia. The bowel mucosa becomes permeable at sites of infarction, permitting the translocation of bacteria and leading to sepsis. [3] [4]", "contents": "Mesenteric Venous Thrombosis -- Pathophysiology. Thrombi within the\u00a0small, more distal venous branches pose\u00a0a risk for bowel infarction. Blood return from the bowel is impeded, resulting in venous engorgement and subsequent ischemia. Arterial spasms can also contribute to irreversible ischemia. The bowel mucosa becomes permeable at sites of infarction, permitting the translocation of bacteria and leading to sepsis. [3] [4]"}
{"id": "article-25022_14", "title": "Mesenteric Venous Thrombosis -- Pathophysiology", "content": "In chronic mesenteric venous thrombosis, collateral circulation develops in the form of extensive cavernoma around the chronically thrombosed area. Often, portal hypertension, varices, and thrombocytopenia coexist with chronic venous thrombosis, and those with portal venous thrombosis have splenomegaly secondary to tissue fibrosis. If the thrombosis is distal to the junction of the left gastric and portal vein, both esophageal and gastric varices are seen. However, if the thrombosis is proximal to this point, gastric varices predominate. [10] [11]", "contents": "Mesenteric Venous Thrombosis -- Pathophysiology. In chronic mesenteric venous thrombosis, collateral circulation develops in the form of extensive cavernoma around the chronically thrombosed area. Often, portal hypertension, varices, and thrombocytopenia coexist with chronic venous thrombosis, and those with portal venous thrombosis have splenomegaly secondary to tissue fibrosis. If the thrombosis is distal to the junction of the left gastric and portal vein, both esophageal and gastric varices are seen. However, if the thrombosis is proximal to this point, gastric varices predominate. [10] [11]"}
{"id": "article-25022_15", "title": "Mesenteric Venous Thrombosis -- Pathophysiology", "content": "Patients with chronic mesenteric venous thrombosis are at risk for many impairments of the gastrointestinal system. Significant bowel edema arises in the setting of\u00a0extensive chronic thrombosis within the portal, superior mesenteric, and splenic veins. Over time, a patient with considerable chronic thrombosis may develop clinically significant small bowel and biliary strictures that can cause malnutrition and cholangitis. [12]", "contents": "Mesenteric Venous Thrombosis -- Pathophysiology. Patients with chronic mesenteric venous thrombosis are at risk for many impairments of the gastrointestinal system. Significant bowel edema arises in the setting of\u00a0extensive chronic thrombosis within the portal, superior mesenteric, and splenic veins. Over time, a patient with considerable chronic thrombosis may develop clinically significant small bowel and biliary strictures that can cause malnutrition and cholangitis. [12]"}
{"id": "article-25022_16", "title": "Mesenteric Venous Thrombosis -- History and Physical", "content": "The history and physical of a patient with\u00a0mesenteric venous thrombosis will vary depending on the acuity and etiology of the thrombosis.\u00a0The presentation can range from an asymptomatic patient whose thrombosis is an incidental finding\u00a0to an acutely ill patient with peritonitis and sepsis. Often, a patient with mesenteric venous thrombosis will\u00a0describe several days of\u00a0diffuse abdominal pain with anorexia, nausea, and vomiting. The history may involve an antecedent infectious or inflammatory condition. Patients may have a personal or family history of thrombosis; this should raise the suspicion of a hereditary coagulopathy. A patient\u00a0with a\u00a0chronic\u00a0mesenteric\u00a0venous thrombosis may have any underlying condition of greater concern, such as portal hypertension. [3] [13]", "contents": "Mesenteric Venous Thrombosis -- History and Physical. The history and physical of a patient with\u00a0mesenteric venous thrombosis will vary depending on the acuity and etiology of the thrombosis.\u00a0The presentation can range from an asymptomatic patient whose thrombosis is an incidental finding\u00a0to an acutely ill patient with peritonitis and sepsis. Often, a patient with mesenteric venous thrombosis will\u00a0describe several days of\u00a0diffuse abdominal pain with anorexia, nausea, and vomiting. The history may involve an antecedent infectious or inflammatory condition. Patients may have a personal or family history of thrombosis; this should raise the suspicion of a hereditary coagulopathy. A patient\u00a0with a\u00a0chronic\u00a0mesenteric\u00a0venous thrombosis may have any underlying condition of greater concern, such as portal hypertension. [3] [13]"}
{"id": "article-25022_17", "title": "Mesenteric Venous Thrombosis -- History and Physical", "content": "In a patient with chronic mesenteric venous thrombosis, the physical examination may be unremarkable, or there may be stigmata of portal hypertension and cirrhosis such as spider nevi, palmar erythema, caput medusae, or evidence of esophageal variceal bleeding. Abdominal distension, discomfort, and ascites may be present. [14]", "contents": "Mesenteric Venous Thrombosis -- History and Physical. In a patient with chronic mesenteric venous thrombosis, the physical examination may be unremarkable, or there may be stigmata of portal hypertension and cirrhosis such as spider nevi, palmar erythema, caput medusae, or evidence of esophageal variceal bleeding. Abdominal distension, discomfort, and ascites may be present. [14]"}
{"id": "article-25022_18", "title": "Mesenteric Venous Thrombosis -- History and Physical", "content": "Patients with acute mesenteric venous thrombi often experience pain out of proportion to physical findings, along with nausea, vomiting, and diarrhea. Fever may indicate a concurrent infection, such as phlebitis, or an intraabdominal process, such as appendicitis or diverticulitis. A patient may exhibit dehydration and hemodynamic instability.", "contents": "Mesenteric Venous Thrombosis -- History and Physical. Patients with acute mesenteric venous thrombi often experience pain out of proportion to physical findings, along with nausea, vomiting, and diarrhea. Fever may indicate a concurrent infection, such as phlebitis, or an intraabdominal process, such as appendicitis or diverticulitis. A patient may exhibit dehydration and hemodynamic instability."}
{"id": "article-25022_19", "title": "Mesenteric Venous Thrombosis -- History and Physical", "content": "Patients with subacute\u00a0mesenteric\u00a0venous thrombosis experience symptoms over days to weeks; the average duration of symptoms varies from 6 to 14 days. In patients with a subacute thrombotic process, abdominal distension may be present, and pain is often mild-to-moderate and diffuse. Ascites may be evident. [12]", "contents": "Mesenteric Venous Thrombosis -- History and Physical. Patients with subacute\u00a0mesenteric\u00a0venous thrombosis experience symptoms over days to weeks; the average duration of symptoms varies from 6 to 14 days. In patients with a subacute thrombotic process, abdominal distension may be present, and pain is often mild-to-moderate and diffuse. Ascites may be evident. [12]"}
{"id": "article-25022_20", "title": "Mesenteric Venous Thrombosis -- Evaluation -- Imaging Studies", "content": "Abdominal imaging is the most useful diagnostic tool to evaluate mesenteric venous thrombosis. An abdominopelvic CT with intravenous contrast can diagnose mesenteric venous thrombosis in 90% of cases.\u00a0Plain abdominal radiographs reveal abnormalities in 50% to 75% of cases\u00a0but demonstrate nonspecific findings\u00a0such as dilated bowel, thumbprinting, and, in cases of perforation, free air. Magnetic resonance imaging (MRI), angiography, and abdominal\u00a0Doppler ultrasonography are less commonly\u00a0employed imaging modalities when evaluating patients with suspected mesenteric venous thrombosis. Abdominal Doppler ultrasonography can detect thrombosis in larger veins but has only 73% to 80% sensitivity and cannot visualize smaller vena recta. [15] [16]", "contents": "Mesenteric Venous Thrombosis -- Evaluation -- Imaging Studies. Abdominal imaging is the most useful diagnostic tool to evaluate mesenteric venous thrombosis. An abdominopelvic CT with intravenous contrast can diagnose mesenteric venous thrombosis in 90% of cases.\u00a0Plain abdominal radiographs reveal abnormalities in 50% to 75% of cases\u00a0but demonstrate nonspecific findings\u00a0such as dilated bowel, thumbprinting, and, in cases of perforation, free air. Magnetic resonance imaging (MRI), angiography, and abdominal\u00a0Doppler ultrasonography are less commonly\u00a0employed imaging modalities when evaluating patients with suspected mesenteric venous thrombosis. Abdominal Doppler ultrasonography can detect thrombosis in larger veins but has only 73% to 80% sensitivity and cannot visualize smaller vena recta. [15] [16]"}
{"id": "article-25022_21", "title": "Mesenteric Venous Thrombosis -- Evaluation -- Imaging Studies", "content": "A venous thrombus will be seen as a focal lucency on CT images. Radiographic signs of\u00a0ischemia include bowel wall thickening greater than 3mm with thickened mesentery and surrounding fluid. In the setting of\u00a0a transmural bowel infarction, the bowel wall may be greater than 10 mm thick. The presence of portal venous gas and pneumatosis suggest necrotic bowel. Intraabdominal free air indicates bowel perforation. [17]", "contents": "Mesenteric Venous Thrombosis -- Evaluation -- Imaging Studies. A venous thrombus will be seen as a focal lucency on CT images. Radiographic signs of\u00a0ischemia include bowel wall thickening greater than 3mm with thickened mesentery and surrounding fluid. In the setting of\u00a0a transmural bowel infarction, the bowel wall may be greater than 10 mm thick. The presence of portal venous gas and pneumatosis suggest necrotic bowel. Intraabdominal free air indicates bowel perforation. [17]"}
{"id": "article-25022_22", "title": "Mesenteric Venous Thrombosis -- Evaluation -- Imaging Studies", "content": "When a mesenteric venous thrombosis is identified on CT, magnetic resonance cholangiopancreatography (MRCP) or endoscopic retrograde cholangiopancreatography (ERCP)\u00a0permits further assessment of the biliary system and degree of portal hypertension; ERCP carries a risk of bleeding from catheter injury. Esophagogastroduodenoscopy (EGD) is recommended to evaluate for esophageal and gastric varices. [18]", "contents": "Mesenteric Venous Thrombosis -- Evaluation -- Imaging Studies. When a mesenteric venous thrombosis is identified on CT, magnetic resonance cholangiopancreatography (MRCP) or endoscopic retrograde cholangiopancreatography (ERCP)\u00a0permits further assessment of the biliary system and degree of portal hypertension; ERCP carries a risk of bleeding from catheter injury. Esophagogastroduodenoscopy (EGD) is recommended to evaluate for esophageal and gastric varices. [18]"}
{"id": "article-25022_23", "title": "Mesenteric Venous Thrombosis -- Evaluation -- Laboratory Testing", "content": "Routine laboratory testing is not\u00a0specific\u00a0for mesenteric\u00a0venous thrombosis but\u00a0provides general clinical information. Recommended laboratory studies include a complete blood count with a differential, comprehensive metabolic panel, coagulation tests, and a thrombophilia screen . An elevated lactate level is a late marker of\u00a0ischemia, and amylase levels can also be elevated with bowel ischemia; amylase levels greater than 1000 U/L suggest pancreatitis. Blood cultures should be obtained from patients with fevers and hemodynamic instability. Patients with portal vein involvement or sepsis will have elevated liver enzymes. [3] [19] [20]", "contents": "Mesenteric Venous Thrombosis -- Evaluation -- Laboratory Testing. Routine laboratory testing is not\u00a0specific\u00a0for mesenteric\u00a0venous thrombosis but\u00a0provides general clinical information. Recommended laboratory studies include a complete blood count with a differential, comprehensive metabolic panel, coagulation tests, and a thrombophilia screen . An elevated lactate level is a late marker of\u00a0ischemia, and amylase levels can also be elevated with bowel ischemia; amylase levels greater than 1000 U/L suggest pancreatitis. Blood cultures should be obtained from patients with fevers and hemodynamic instability. Patients with portal vein involvement or sepsis will have elevated liver enzymes. [3] [19] [20]"}
{"id": "article-25022_24", "title": "Mesenteric Venous Thrombosis -- Treatment / Management", "content": "Treatment for acute and subacute mesenteric venous thromboses can range from bowel rest, resuscitation, and anticoagulation to extensive surgery with bowel resection. Treatment\u00a0goals are to prevent bowel infarction, mitigate blot extension,\u00a0and minimize recurrence risk. Initial treatment depends on clinical presentation, the acuity of the thrombosis, and the underlying etiology. Stable patients may be treated nonoperatively with bowel rest, electrolyte replacement, and anticoagulation. Nasogastric decompression is often necessary, and total parenteral nutrition may be\u00a0indicated. Febrile patients may benefit from broad-spectrum antibiotics\u00a0to treat thrombophlebitis or enteric bacterial translocation. [21]", "contents": "Mesenteric Venous Thrombosis -- Treatment / Management. Treatment for acute and subacute mesenteric venous thromboses can range from bowel rest, resuscitation, and anticoagulation to extensive surgery with bowel resection. Treatment\u00a0goals are to prevent bowel infarction, mitigate blot extension,\u00a0and minimize recurrence risk. Initial treatment depends on clinical presentation, the acuity of the thrombosis, and the underlying etiology. Stable patients may be treated nonoperatively with bowel rest, electrolyte replacement, and anticoagulation. Nasogastric decompression is often necessary, and total parenteral nutrition may be\u00a0indicated. Febrile patients may benefit from broad-spectrum antibiotics\u00a0to treat thrombophlebitis or enteric bacterial translocation. [21]"}
{"id": "article-25022_25", "title": "Mesenteric Venous Thrombosis -- Treatment / Management", "content": "Significant clot burden and clinical deterioration warrant invasive intervention. Historically, the\u00a0only\u00a0option for urgent intervention was open surgery. Interventional radiology (IR) can offer\u00a0precise therapy such as catheter-directed thrombolysis, thrombectomy, and focal administration of pharmacologic agents, including papaverine for vasodilation, or tissue-type plasminogen activator (tPA) or streptokinase for clot lysis. These IR measures often\u00a0result in symptomatic improvement and lower bowel resection rates, even with persistent radiographic thrombus. [3]", "contents": "Mesenteric Venous Thrombosis -- Treatment / Management. Significant clot burden and clinical deterioration warrant invasive intervention. Historically, the\u00a0only\u00a0option for urgent intervention was open surgery. Interventional radiology (IR) can offer\u00a0precise therapy such as catheter-directed thrombolysis, thrombectomy, and focal administration of pharmacologic agents, including papaverine for vasodilation, or tissue-type plasminogen activator (tPA) or streptokinase for clot lysis. These IR measures often\u00a0result in symptomatic improvement and lower bowel resection rates, even with persistent radiographic thrombus. [3]"}
{"id": "article-25022_26", "title": "Mesenteric Venous Thrombosis -- Treatment / Management", "content": "During an IR procedure, access is obtained percutaneously via a transjugular or transhepatic approach. [22] [23] A\u00a04F or 5F angiographic catheter over a 0.035-inch hydrophilic guidewire is used to cross the thrombus. The angiographic catheter is exchanged with a multi-sidehole perfusion catheter, and the tip is placed in the mesenteric vein. If using tPA, an initial dose of 5\u00a0mg is given, followed by continuous tPA infusion at 0.5\u00a0mg/h.\u00a0Heparin sodium 40 mg every 12 hours and 80,0000 U/day of urokinase can also be used.\u00a0A post-procedural venogram is performed.\u00a0Contraindications for catheter-directed fibrinolysis include\u00a0intracranial hemorrhage, a history of stroke, primary or metastatic central nervous system disease, recent\u00a0surgery, trauma, and mesenteric infarction. [21] [22] [23]", "contents": "Mesenteric Venous Thrombosis -- Treatment / Management. During an IR procedure, access is obtained percutaneously via a transjugular or transhepatic approach. [22] [23] A\u00a04F or 5F angiographic catheter over a 0.035-inch hydrophilic guidewire is used to cross the thrombus. The angiographic catheter is exchanged with a multi-sidehole perfusion catheter, and the tip is placed in the mesenteric vein. If using tPA, an initial dose of 5\u00a0mg is given, followed by continuous tPA infusion at 0.5\u00a0mg/h.\u00a0Heparin sodium 40 mg every 12 hours and 80,0000 U/day of urokinase can also be used.\u00a0A post-procedural venogram is performed.\u00a0Contraindications for catheter-directed fibrinolysis include\u00a0intracranial hemorrhage, a history of stroke, primary or metastatic central nervous system disease, recent\u00a0surgery, trauma, and mesenteric infarction. [21] [22] [23]"}
{"id": "article-25022_27", "title": "Mesenteric Venous Thrombosis -- Treatment / Management", "content": "Open surgery is indicated if a patient becomes septic from ischemic bowel or a perforated viscus. The area of thrombosis is identified, and the affected bowel segment is resected. The goal of surgery is\u00a0bowel conservation while resecting necrotic segments, and the average length of resection is 50 to 60 cm. Intraoperative Doppler ultrasonography may be used to assess the mesenteric blood supply. The surgeon may return in 24 hours for a second look before completing the anastomosis if there are concerns for ongoing ischemia. [2] [20] [24] [25]", "contents": "Mesenteric Venous Thrombosis -- Treatment / Management. Open surgery is indicated if a patient becomes septic from ischemic bowel or a perforated viscus. The area of thrombosis is identified, and the affected bowel segment is resected. The goal of surgery is\u00a0bowel conservation while resecting necrotic segments, and the average length of resection is 50 to 60 cm. Intraoperative Doppler ultrasonography may be used to assess the mesenteric blood supply. The surgeon may return in 24 hours for a second look before completing the anastomosis if there are concerns for ongoing ischemia. [2] [20] [24] [25]"}
{"id": "article-25022_28", "title": "Mesenteric Venous Thrombosis -- Treatment / Management", "content": "Anticoagulation is the cornerstone of mesenteric venous thrombosis treatment. While there remains a possibility of invasive intervention, or for patients with renal insufficiency, the initial anticoagulant of choice is unfractionated heparin. Once the patient is stable, the anticoagulant is changed to an oral medication such as warfarin or a direct oral anticoagulant (DOAC). Patients with reversible causes of thrombosis should complete a 6-month course of anticoagulation therapy, while those with heritable or acquired thrombotic states continue lifelong anticoagulation.", "contents": "Mesenteric Venous Thrombosis -- Treatment / Management. Anticoagulation is the cornerstone of mesenteric venous thrombosis treatment. While there remains a possibility of invasive intervention, or for patients with renal insufficiency, the initial anticoagulant of choice is unfractionated heparin. Once the patient is stable, the anticoagulant is changed to an oral medication such as warfarin or a direct oral anticoagulant (DOAC). Patients with reversible causes of thrombosis should complete a 6-month course of anticoagulation therapy, while those with heritable or acquired thrombotic states continue lifelong anticoagulation."}
{"id": "article-25022_29", "title": "Mesenteric Venous Thrombosis -- Treatment / Management", "content": "Despite the risks, anticoagulation remains the mainstay of management, even in those patients with portal venous thrombosis who have cirrhosis and portal hypertension.\u00a0Anticoagulation helps recanalize the vein. Patients with mesenteric venous thrombosis awaiting liver transplantation who receive anticoagulation experience recanalization in 50% of cases, while those not taking anticoagulation do not experience recanalization of the portal vein. Factors associated with failure of recanalization include splenic vein involvement, ascites, and significant clot burden. [3]", "contents": "Mesenteric Venous Thrombosis -- Treatment / Management. Despite the risks, anticoagulation remains the mainstay of management, even in those patients with portal venous thrombosis who have cirrhosis and portal hypertension.\u00a0Anticoagulation helps recanalize the vein. Patients with mesenteric venous thrombosis awaiting liver transplantation who receive anticoagulation experience recanalization in 50% of cases, while those not taking anticoagulation do not experience recanalization of the portal vein. Factors associated with failure of recanalization include splenic vein involvement, ascites, and significant clot burden. [3]"}
{"id": "article-25022_30", "title": "Mesenteric Venous Thrombosis -- Treatment / Management", "content": "Patients with portal hypertension may require intervention such as a transjugular intrahepatic portosystemic shunt (TIPS) to minimize bleeding risks before anticoagulation. The goal of a TIPS is mechanical recanalization of the portal vein\u00a0to maintain flow across the occluded segment. In patients with cirrhosis, a shunt can be created between the left portal vein and the superior mesenteric vein, and splenectomy is effective in those patients with isolated gastric varices from splenic vein thrombosis. Stenting may be required for biliary strictures formed as a consequence of chronic portal vein thrombosis. Rarely a hepaticojejunostomy is required to\u00a0overcome the stenotic bile ducts. [26] [27]", "contents": "Mesenteric Venous Thrombosis -- Treatment / Management. Patients with portal hypertension may require intervention such as a transjugular intrahepatic portosystemic shunt (TIPS) to minimize bleeding risks before anticoagulation. The goal of a TIPS is mechanical recanalization of the portal vein\u00a0to maintain flow across the occluded segment. In patients with cirrhosis, a shunt can be created between the left portal vein and the superior mesenteric vein, and splenectomy is effective in those patients with isolated gastric varices from splenic vein thrombosis. Stenting may be required for biliary strictures formed as a consequence of chronic portal vein thrombosis. Rarely a hepaticojejunostomy is required to\u00a0overcome the stenotic bile ducts. [26] [27]"}
{"id": "article-25022_31", "title": "Mesenteric Venous Thrombosis -- Differential Diagnosis", "content": "The symptoms of mesenteric venous thrombosis can be vague and nonspecific and range from mild to severe. Physical examination and laboratory values alone generate a broad differential diagnosis,\u00a0including a spectrum of intraabdominal pathology,\u00a0myocardial infarction, and aortic dissection. It is also essential to distinguish mesenteric venous thrombosis from mesenteric arterial thrombosis, as the etiology and approach to treatment are different.\u00a0Mesenteric venous thrombosis may exist concurrently with an inciting infectious or inflammatory process.", "contents": "Mesenteric Venous Thrombosis -- Differential Diagnosis. The symptoms of mesenteric venous thrombosis can be vague and nonspecific and range from mild to severe. Physical examination and laboratory values alone generate a broad differential diagnosis,\u00a0including a spectrum of intraabdominal pathology,\u00a0myocardial infarction, and aortic dissection. It is also essential to distinguish mesenteric venous thrombosis from mesenteric arterial thrombosis, as the etiology and approach to treatment are different.\u00a0Mesenteric venous thrombosis may exist concurrently with an inciting infectious or inflammatory process."}
{"id": "article-25022_32", "title": "Mesenteric Venous Thrombosis -- Prognosis", "content": "While overall mortality has decreased due to earlier diagnosis and treatment, mesenteric venous thrombosis remains a life-threatening condition, and a delay in diagnosis directly correlates with worse outcomes. The most common causes of death in patients with mesenteric venous thrombosis are sepsis, pulmonary emboli, and the sequelae from recurrent thrombi.\u00a0Patient age, comorbidities, time to diagnosis, and successful revascularization\u00a0impact outcomes. [21]", "contents": "Mesenteric Venous Thrombosis -- Prognosis. While overall mortality has decreased due to earlier diagnosis and treatment, mesenteric venous thrombosis remains a life-threatening condition, and a delay in diagnosis directly correlates with worse outcomes. The most common causes of death in patients with mesenteric venous thrombosis are sepsis, pulmonary emboli, and the sequelae from recurrent thrombi.\u00a0Patient age, comorbidities, time to diagnosis, and successful revascularization\u00a0impact outcomes. [21]"}
{"id": "article-25022_33", "title": "Mesenteric Venous Thrombosis -- Prognosis", "content": "Acute mesenteric venous thrombosis has a 30-day mortality of up to 32%.\u00a0Timely diagnosis reduces mortality to less than 10%; the mortality rate approaches 60% when diagnosis is delayed. [28] [21] If treatment is delayed longer than 24 hours from symptom onset, mortality ranges between 80% and 100%. [29] For patients with chronic mesenteric venous thrombosis, 5-year survival rates are up to 82%. In the paradigm of chronic thrombosis, the prognosis is determined by the severity of the underlying condition. [30]", "contents": "Mesenteric Venous Thrombosis -- Prognosis. Acute mesenteric venous thrombosis has a 30-day mortality of up to 32%.\u00a0Timely diagnosis reduces mortality to less than 10%; the mortality rate approaches 60% when diagnosis is delayed. [28] [21] If treatment is delayed longer than 24 hours from symptom onset, mortality ranges between 80% and 100%. [29] For patients with chronic mesenteric venous thrombosis, 5-year survival rates are up to 82%. In the paradigm of chronic thrombosis, the prognosis is determined by the severity of the underlying condition. [30]"}
{"id": "article-25022_34", "title": "Mesenteric Venous Thrombosis -- Complications", "content": "Complications of mesenteric venous thrombosis arise from the thrombosis, the treatments, and the\u00a0underlying condition.\u00a0Thrombosis recurrence usually occurs within the first 30 days and may be as low as 0% to 3% in those who receive anticoagulation. Recurrence or extension of thrombosis may give rise to bowel infarction, sepsis, and death. Short bowel syndrome may be a consequence of bowel resection, and some patients require lifelong total parenteral nutrition. [31]", "contents": "Mesenteric Venous Thrombosis -- Complications. Complications of mesenteric venous thrombosis arise from the thrombosis, the treatments, and the\u00a0underlying condition.\u00a0Thrombosis recurrence usually occurs within the first 30 days and may be as low as 0% to 3% in those who receive anticoagulation. Recurrence or extension of thrombosis may give rise to bowel infarction, sepsis, and death. Short bowel syndrome may be a consequence of bowel resection, and some patients require lifelong total parenteral nutrition. [31]"}
{"id": "article-25022_35", "title": "Mesenteric Venous Thrombosis -- Complications", "content": "Complications from catheter-directed thrombolysis include major and minor bleeding, fever, hematoma formation, pain, and infection. Transhepatic access for thrombolytic therapy carries an increased risk of bleeding, and\u00a0the transileocolic approach may require surgical access. The bleeding risk from anticoagulation is less than 10%, and\u00a0bleeding is usually within the gastrointestinal system.\u00a0Patients with varices have a higher bleeding risk and should be pretreated with beta blockers or undergo definitive management of varices. [21] [32]", "contents": "Mesenteric Venous Thrombosis -- Complications. Complications from catheter-directed thrombolysis include major and minor bleeding, fever, hematoma formation, pain, and infection. Transhepatic access for thrombolytic therapy carries an increased risk of bleeding, and\u00a0the transileocolic approach may require surgical access. The bleeding risk from anticoagulation is less than 10%, and\u00a0bleeding is usually within the gastrointestinal system.\u00a0Patients with varices have a higher bleeding risk and should be pretreated with beta blockers or undergo definitive management of varices. [21] [32]"}
{"id": "article-25022_36", "title": "Mesenteric Venous Thrombosis -- Complications", "content": "Chronic thrombosis can give rise to biliary strictures, gallstones, and recurrent cholangitis; major reconstructive surgery is required occasionally. The myeloproliferative neoplasms that predispose some patients to thrombosis can convert to leukemia and myelodysplasia.\u00a0Patients with chronic thrombosis also suffer from chronic fatigue, bone pain, pruritis, weight loss, and bleeding from platelet dysfunction. [12]", "contents": "Mesenteric Venous Thrombosis -- Complications. Chronic thrombosis can give rise to biliary strictures, gallstones, and recurrent cholangitis; major reconstructive surgery is required occasionally. The myeloproliferative neoplasms that predispose some patients to thrombosis can convert to leukemia and myelodysplasia.\u00a0Patients with chronic thrombosis also suffer from chronic fatigue, bone pain, pruritis, weight loss, and bleeding from platelet dysfunction. [12]"}
{"id": "article-25022_37", "title": "Mesenteric Venous Thrombosis -- Postoperative and Rehabilitation Care", "content": "The intensity of postoperative and rehabilitative care depends on the etiology and clinical impact\u00a0of the mesenteric venous thrombosis. Those who progress to multisystem organ failure requiring critical care support will face a long recovery period with many potential pitfalls, including recurrent thrombus, pulmonary emboli, gastrointestinal bleeding, need for prolonged invasive ventilation, and parenteral nutrition.\u00a0Those\u00a0patients who\u00a0underwent surgery may require repeat surgical interventions, possible intestinal reconstruction, and delayed abdominal closure. A subset of patients will require\u00a0chronic nutritional monitoring and supplementation. Lifelong anticoagulation is indicated in\u00a0those patients for whom the etiology of the venous thrombosis was idiopathic or secondary to a chronic condition.", "contents": "Mesenteric Venous Thrombosis -- Postoperative and Rehabilitation Care. The intensity of postoperative and rehabilitative care depends on the etiology and clinical impact\u00a0of the mesenteric venous thrombosis. Those who progress to multisystem organ failure requiring critical care support will face a long recovery period with many potential pitfalls, including recurrent thrombus, pulmonary emboli, gastrointestinal bleeding, need for prolonged invasive ventilation, and parenteral nutrition.\u00a0Those\u00a0patients who\u00a0underwent surgery may require repeat surgical interventions, possible intestinal reconstruction, and delayed abdominal closure. A subset of patients will require\u00a0chronic nutritional monitoring and supplementation. Lifelong anticoagulation is indicated in\u00a0those patients for whom the etiology of the venous thrombosis was idiopathic or secondary to a chronic condition."}
{"id": "article-25022_38", "title": "Mesenteric Venous Thrombosis -- Consultations", "content": "It is important to include interventional radiology and general surgery in the decision-making early in the clinical course of patients diagnosed with mesenteric venous thrombosis.\u00a0Pharmacists also play an important role in helping to administer anticoagulation and fibrinolytic therapy. Additional frequently needed consultants include nutritionists and intensivists.", "contents": "Mesenteric Venous Thrombosis -- Consultations. It is important to include interventional radiology and general surgery in the decision-making early in the clinical course of patients diagnosed with mesenteric venous thrombosis.\u00a0Pharmacists also play an important role in helping to administer anticoagulation and fibrinolytic therapy. Additional frequently needed consultants include nutritionists and intensivists."}
{"id": "article-25022_39", "title": "Mesenteric Venous Thrombosis -- Deterrence and Patient Education", "content": "It is important to identify those patients who may be at an increased risk for developing mesenteric venous thrombosis, such as those with a personal or family history of blood clots, chronic inflammatory conditions, or known portal hypertension and cirrhosis. These individuals should understand the importance of seeking prompt medical evaluation for severe or unrelenting abdominal pain. A subset of patients with increased risk may benefit from prophylactic anticoagulation. [33]", "contents": "Mesenteric Venous Thrombosis -- Deterrence and Patient Education. It is important to identify those patients who may be at an increased risk for developing mesenteric venous thrombosis, such as those with a personal or family history of blood clots, chronic inflammatory conditions, or known portal hypertension and cirrhosis. These individuals should understand the importance of seeking prompt medical evaluation for severe or unrelenting abdominal pain. A subset of patients with increased risk may benefit from prophylactic anticoagulation. [33]"}
{"id": "article-25022_40", "title": "Mesenteric Venous Thrombosis -- Pearls and Other Issues", "content": "Severe pain in the absence of definitive physical findings should raise the suspicion for a mesenteric venous thrombosis. While the finding of ascites confers a broad differential diagnosis, mesenteric venous thrombosis should always be considered in this setting. Any radiographic diagnosis of venous thrombosis should prompt a thorough evaluation for either a local source, such as inflammation, infection, intraabdominal malignancy, or a heritable or acquired thrombophilic condition. Individuals with a personal or family history of deep vein thrombosis or other thrombophilia presenting with acute abdominal pain should be promptly evaluated for mesenteric venous thrombosis.", "contents": "Mesenteric Venous Thrombosis -- Pearls and Other Issues. Severe pain in the absence of definitive physical findings should raise the suspicion for a mesenteric venous thrombosis. While the finding of ascites confers a broad differential diagnosis, mesenteric venous thrombosis should always be considered in this setting. Any radiographic diagnosis of venous thrombosis should prompt a thorough evaluation for either a local source, such as inflammation, infection, intraabdominal malignancy, or a heritable or acquired thrombophilic condition. Individuals with a personal or family history of deep vein thrombosis or other thrombophilia presenting with acute abdominal pain should be promptly evaluated for mesenteric venous thrombosis."}
{"id": "article-25022_41", "title": "Mesenteric Venous Thrombosis -- Enhancing Healthcare Team Outcomes", "content": "Mesenteric venous\u00a0thrombosis can be challenging to diagnose and treat\u00a0and\u00a0requires collaboration amongst the\u00a0interprofessional team, including internal medicine providers, surgeons, interventional radiologists, critical care specialists, and pharmacists. Patients diagnosed with mesenteric venous thrombosis require close monitoring, and\u00a0patient outcomes depend on timely communication between the interprofessional team, and the ability to rapidly adjust to clinical circumstances.", "contents": "Mesenteric Venous Thrombosis -- Enhancing Healthcare Team Outcomes. Mesenteric venous\u00a0thrombosis can be challenging to diagnose and treat\u00a0and\u00a0requires collaboration amongst the\u00a0interprofessional team, including internal medicine providers, surgeons, interventional radiologists, critical care specialists, and pharmacists. Patients diagnosed with mesenteric venous thrombosis require close monitoring, and\u00a0patient outcomes depend on timely communication between the interprofessional team, and the ability to rapidly adjust to clinical circumstances."}
{"id": "article-25022_42", "title": "Mesenteric Venous Thrombosis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Mesenteric Venous Thrombosis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}